Ethic Inc. reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 4.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 26,614 shares of the medical equipment provider's stock after selling 1,270 shares during the period. Ethic Inc.'s holdings in Intuitive Surgical were worth $14,204,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently modified their holdings of ISRG. Chilton Capital Management LLC boosted its holdings in Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after acquiring an additional 43 shares during the period. Elite Financial Inc. acquired a new stake in shares of Intuitive Surgical during the first quarter valued at about $26,000. LFA Lugano Financial Advisors SA acquired a new position in shares of Intuitive Surgical in the first quarter worth about $30,000. TD Capital Management LLC boosted its holdings in Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock valued at $30,000 after purchasing an additional 45 shares during the last quarter. Finally, 1248 Management LLC acquired a new stake in Intuitive Surgical during the 1st quarter valued at approximately $30,000. Institutional investors and hedge funds own 83.64% of the company's stock.
Insider Buying and Selling at Intuitive Surgical
In other news, EVP Myriam Curet sold 4,500 shares of the company's stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares of the company's stock, valued at approximately $173,845.44. This represents a 92.73% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Amy L. Ladd sold 336 shares of the business's stock in a transaction that occurred on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total value of $157,956.96. Following the sale, the director directly owned 1,074 shares in the company, valued at approximately $504,898.14. The trade was a 23.83% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 45,224 shares of company stock valued at $21,716,492. Company insiders own 0.70% of the company's stock.
Analysts Set New Price Targets
Several research firms have recently commented on ISRG. Leerink Partners increased their target price on Intuitive Surgical from $593.00 to $600.00 and gave the company an "outperform" rating in a research note on Wednesday. UBS Group set a $529.00 price objective on shares of Intuitive Surgical in a research note on Monday, October 13th. Robert W. Baird dropped their target price on shares of Intuitive Surgical from $600.00 to $536.00 and set an "outperform" rating for the company in a research report on Wednesday, October 15th. Deutsche Bank Aktiengesellschaft restated a "sell" rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Finally, BTIG Research boosted their price objective on Intuitive Surgical from $529.00 to $589.00 and gave the company a "buy" rating in a report on Wednesday. Sixteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Intuitive Surgical has an average rating of "Moderate Buy" and a consensus target price of $590.86.
Read Our Latest Analysis on ISRG
Intuitive Surgical Stock Up 15.4%
ISRG stock opened at $533.84 on Wednesday. The firm's 50-day simple moving average is $454.39 and its 200 day simple moving average is $495.58. The stock has a market cap of $191.37 billion, a PE ratio of 75.00, a price-to-earnings-growth ratio of 4.81 and a beta of 1.61. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating analysts' consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.51 billion for the quarter, compared to analysts' expectations of $2.41 billion. During the same quarter in the previous year, the company posted $1.84 earnings per share. The business's revenue for the quarter was up 22.9% compared to the same quarter last year. Equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.
Intuitive Surgical Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.